XERS - Xeris Biopharma Holdings, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	38.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+378%)	42.8% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+435%)	37.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+363%)	48.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+510%)	47.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+499%)	35.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+342%)	12.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+54%)	26.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+231%)	—	—	62.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+682%)	50.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+527%)	—	—	169.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2017%)	184.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2202%)	169.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2017%)	202.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2429%)	17.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+117%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	N/M	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	90.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	57.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-22.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	43.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	26.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	53.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	16.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	51.4% Excellent ↓ Excellent Declining Year-over-year change in net income	51.4% Excellent ↑ Excellent Improving Year-over-year change in net income	51.4% Excellent ↑ Excellent Improving Year-over-year change in net income	61.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.7% Weak Weak Year-over-year change in net income	-12.7% Weak Weak Year-over-year change in net income	—	—	50.1% Excellent Excellent Year-over-year change in net income	50.1% Excellent Excellent Year-over-year change in net income	—	—	-83.1% Weak ↑ Weak Improving Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-132.4% Weak Weak Year-over-year change in net income	36.9% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	—	—	54.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	49.6% Excellent Excellent Year-over-year change in free cash flow	8.3% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	35.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	41.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	39.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	41.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	70.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	75.4% Excellent → Excellent Stable Compound annual revenue growth over 3 years	70.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	84.3% Excellent Excellent Compound annual revenue growth over 3 years	72.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	58.9% Excellent → Excellent Stable Compound annual revenue growth over 5 years	64.7% Excellent Excellent Compound annual revenue growth over 5 years	51.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	9.5% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	19.5% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+30%)	9.0% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-40%)	6.3% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	-5.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-134%)	2.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	-23.8% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-258%)	-17.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-214%)	-35.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-334%)	-22.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-248%)	-10.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-168%)	-42.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-380%)	—	—	-63.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-521%)	-74.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-598%)	-131.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-978%)	-225.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1602%)	-220.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1572%)	-289.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2030%)	-204.3% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1462%)	-272.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1919%)	-146.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1074%)	—	—	—
Profit Margin (%) (%)	2.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-78%)	12.9% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+8%)	-12.4% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-12.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-207%)	-15.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-228%)	-8.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-171%)	-35.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-391%)	-39.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-429%)	-46.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-489%)	-30.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-351%)	-34.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-390%)	-44.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-469%)	—	—	-113.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1045%)	-133.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1210%)	-152.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1373%)	-237.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2075%)	-166.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1490%)	-206.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1823%)	-224.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1972%)	-308.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2669%)	-310.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2686%)	—	—	—
FCF Margin (%) (%)	11.9% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	23.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	24.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	0.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-16.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	3.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-50.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	16.8% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-81.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-219.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-135.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-224.8% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-292.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-156.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	4.42x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.81x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-2.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	-0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	-0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.30x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	2.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.7% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	2.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	0.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	122.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	114.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-92.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-7.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-102.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-75.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	2.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	4.4% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	1.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	1.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	0.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-2.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-1.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-18.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	17.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+14%)	80.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+440%)	—	47.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+218%)	26.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+75%)	17.3% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	67.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+347%)	98.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+556%)	206.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1279%)	197.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1216%)	—	-123.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-923%)	—	—	-61.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-508%)	-45.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-404%)	-35.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	-53.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-456%)	—	-92.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-717%)	-41.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-377%)	-64.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-532%)	-203.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1457%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	17.00x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2734%)	16.10x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+2583%)	-254.90x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42583%)	-11.33x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1988%)	-6.54x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1190%)	-7.84x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1406%)	-7.63x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1372%)	-11.95x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2092%)	—	—	49.27x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+8111%)	—	—	4.14x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+590%)	2.52x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+319%)	1.87x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+211%)	1.43x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+138%)	—	-35.64x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-6040%)	—	—	2.58x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+330%)	—	—	—	—
Interest Coverage (x)	1.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	2.41x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	0.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	0.28x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-9.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-0.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-4.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-26.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.55x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$109.47M	$109.29M	$127.87M	$159.34M	$171.32M	$160.49M	$157.00M	$172.88M	$-62.69M	$-67.45M	$144.28M	$-46.17M	—	$65.11M	$54.40M	$42.73M	$33.87M	—	$28.22M	—	—	$49.42M	$-37.89M	—	—	$-19.52M
Debt / EBITDA (x)	26.81x Weak ↓ Weak Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	12.88x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	31.05x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	45.48x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-82.80x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	116.52x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-16.77x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-28.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-38.76x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-7.38x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-7.44x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.79x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-3.60x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-4.61x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.49	—	$0.45	$0.45	$0.39	—	$0.36	$0.32	$0.29	—	$0.35	$0.28	—	—	$0.22	$0.19	$0.16	—	—	$0.13	$0.13	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.01	$0.07	$0.00	$-0.01	$-0.06	$-0.03	$-0.11	$-0.10	$-0.14	$-0.09	$-0.09	$-0.14	—	—	$-0.16	$-0.19	$-0.25	$-0.44	—	$-0.41	$-0.30	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.06	—	$0.11	$0.00	$-0.07	—	—	—	$-0.14	—	—	—	—	—	—	$-0.15	$-0.36	—	—	$-0.30	$-0.39	—	—	—	—	—
Book Value per Share (USD)	$0.08	$0.08	$-0.01	$-0.12	$-0.23	$-0.20	$-0.19	$-0.13	$-0.07	—	$0.03	$0.10	—	$0.33	$0.40	$0.55	$0.71	—	$-0.04	$0.30	$0.72	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.55	$-0.59	$-0.69	$-0.84	$-0.99	$-1.01	$-1.03	$-0.98	$-0.07	—	$-0.95	$0.10	—	$-0.72	$-0.67	$-0.55	$-0.41	—	$-0.04	$0.30	$0.72	—	—	—	—	—
Basic Weighted Avg Shares (shares)	170.52M	—	163.65M	159.46M	152.45M	—	148.99M	148.35M	140.51M	—	138.06M	137.34M	—	—	135.95M	135.53M	135.03M	—	—	66.37M	61.25M	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$133.09M	$130.74M	$107.82M	$90.41M	$68.42M	$67.22M	$71.79M	$94.85M	—	—	$71.01M	—	—	$113.20M	$80.36M	$96.66M	$111.06M	—	$87.08M	—	—	$124.00M	—	—	—	—
LT Debt (USD)	$221.22M	$220.34M	$219.47M	$218.63M	$229.76M	$232.11M	$216.23M	$230.48M	—	—	$190.42M	—	—	$187.07M	$138.51M	$138.07M	$137.64M	—	$87.71M	—	—	$87.02M	—	—	—	—
Total Equity (USD)	$13.01M	$13.69M	$-861.00K	$-19.30M	$-35.13M	$-29.61M	$-28.32M	$-19.29M	$-9.18M	$-6.78M	$3.87M	$13.64M	$30.05M	$45.19M	$55.04M	$73.94M	$96.45M	$95.23M	$-2.46M	$19.89M	$44.39M	$33.76M	$14.34M	$24.38M	$27.07M	$14.44M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$83.13M	$85.81M	$74.38M	$71.54M	$60.12M	$60.10M	$54.27M	$48.06M	$40.64M	$44.39M	$48.32M	$38.01M	—	—	$29.73M	$25.31M	$22.07M	$21.43M	$11.04M	$8.91M	$8.20M	$7.09M	$9.40M	—	—	—
Depreciation Expense (USD)	$337.00K	$335.00K	$338.00K	$325.00K	$315.00K	$313.00K	—	—	$326.00K	$346.00K	—	—	—	—	—	$352.00K	$321.00K	$349.00K	—	$320.00K	$337.00K	$446.00K	—	—	—	—
Net Income, GAAP (USD)	$2.23M	$11.08M	$-9.22M	$-9.22M	$-9.22M	$-5.11M	$-18.98M	$-18.98M	$-18.98M	$-13.39M	$-16.83M	$-16.83M	—	—	$-33.71M	$-33.71M	$-33.71M	$-50.79M	$-18.41M	$-18.41M	$-18.41M	$-21.86M	$-29.18M	—	—	—
Operating Cash Flow (USD)	$9.87M	$20.04M	$18.43M	$182.00K	$-10.03M	$1.98M	—	—	$-20.30M	$7.47M	—	—	—	—	—	$-20.61M	$-48.41M	$-28.95M	—	$-20.02M	$-23.96M	$-10.87M	—	—	—	—

Xeris Biopharma Holdings, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare XERS with peers